NLRP3 and early-onset autosomal dominant Alzheimer disease: After discovering that amyloid-β triggers NLRP3 signaling in vitro, Heneka et al. provided evidence suggesting that the NLRP3 inflammasome is crucial in driving Alzheimer’s disease in vivo [34].